Key result
MaxiK β1-subunit reduces thromboxane A2 analog potency, increasing aortic contraction EC50 by ~100%.
Absolute Event Rate: 18% vs 9%
p-value: p=<0.001
The MaxiK β1-subunit associates with the thromboxane A2 receptor, counteracting its vasoconstricting effects and modifying its actions.
Hypothesis-generating for TP-MaxiK coupling in coronary tone; leaves open in vivo relevance and clinical translation.
The large conductance voltage- and Ca 2+ -activated K + channel (MaxiK, BK Ca , BK) is composed of four pore-forming α-subunits and can be associated with regulatory β-subunits. One of the functional roles of MaxiK is to regulate vascular tone. We recently found that the MaxiK channel from coronary smooth muscle is trans -inhibited by activation of the vasoconstricting thromboxane A 2 prostanoid receptor (TP), a mechanism supported by MaxiK α-subunit (MaxiKα)-TP physical interaction. Here, we examined the role of the MaxiK β1-subunit in TP-MaxiK association. We found that the β1-subunit can by itself interact with TP and that this association can occur independently of MaxiKα. Subcellular localization analysis revealed that β1 and TP are closely associated at the cell periphery. The molecular mechanism of β1-TP interaction involves predominantly the β1 extracellular loop. As reported previously, TP activation by the thromboxane A 2 analog U46619 caused inhibition of MaxiKα macroscopic conductance or fractional open probability ( FP o ) as a function of voltage. However, the positive shift of the FP o versus voltage curve by U46619 relative to the control was less prominent when β1 was coexpressed with TP and MaxiKα proteins (20 ± 6 mV, n = 7) than in cells expressing TP and MaxiKα alone (51 ± 7 mV, n = 7). Finally, β1 gene ablation reduced the EC 50 of the U46619 agonist in mediating aortic contraction from 18 ± 1 nm ( n = 12) to 9 ± 1 nm ( n = 12). The results indicate that the β1-subunit can form a tripartite complex with TP and MaxiKα, has the ability to associate with each protein independently, and diminishes U46619-induced MaxiK channel trans -inhibition as well as vasoconstriction. Background: The vasoconstricting thromboxane A 2 prostanoid receptor (TP) is physically coupled to the MaxiK channel α-subunit, down-regulating its activity, but the role of the MaxiK β1-subunit is unknown. Results: The MaxiK β1-subunit can interact with TP independently of the MaxiK α-subunit and counteracts activated TP-induced current inhibition, and its ablation increases TP vasoconstricting potency. Conclusion: The β1-subunit modifies TP actions. Significance: This is the first demonstration that the MaxiK β1-subunit associates with a vasoconstricting receptor.
No takes yet. Share an insight, caveat, or question.
Li et al. (2012) studied this question. β1-subunit expression vs. β1 knock-out (absence of β1-subunit) was evaluated on U46619-induced aortic contraction (EC50) (p=<0.001). The presence of the MaxiK β1-subunit reduced the potency of the thromboxane A2 analog U46619 in mediating aortic contraction, increasing the EC50 from 9 nM to 18 nM.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: